Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China
· Delayed Price · Currency is CNY 11.47
-0.05 (-0.43%)
Apr 29, 2026, 3:00 PM CST
SHA:600267 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 13,321 | 11,503 | 9,700 | 11,133 | 12,936 | 16,732 | Upgrade
|
| Market Cap Growth | 25.81% | 18.59% | -12.87% | -13.94% | -22.69% | 4.84% | Upgrade
|
| Enterprise Value | 15,211 | 13,638 | 13,151 | 15,743 | 18,163 | 23,563 | Upgrade
|
| Last Close Price | 11.47 | 9.89 | 8.10 | 9.14 | 10.61 | 13.34 | Upgrade
|
| PE Ratio | 19.22 | 21.28 | 16.14 | - | 26.46 | 34.37 | Upgrade
|
| Forward PE | 25.21 | 160.67 | 160.67 | 160.67 | 160.67 | 160.67 | Upgrade
|
| PS Ratio | 1.29 | 1.09 | 0.94 | 1.07 | 1.08 | 1.38 | Upgrade
|
| PB Ratio | 1.50 | 1.30 | 1.13 | 1.33 | 1.55 | 2.28 | Upgrade
|
| P/TBV Ratio | 1.72 | 1.48 | 1.31 | 1.58 | 1.92 | 2.84 | Upgrade
|
| P/FCF Ratio | - | 6.95 | 4.99 | 8.82 | 8.43 | 15.02 | Upgrade
|
| P/OCF Ratio | - | 5.66 | 4.44 | 7.41 | 6.26 | 9.64 | Upgrade
|
| EV/Sales Ratio | 1.48 | 1.29 | 1.27 | 1.52 | 1.51 | 1.94 | Upgrade
|
| EV/EBITDA Ratio | 6.73 | 6.69 | 7.60 | 11.64 | 9.15 | 13.11 | Upgrade
|
| EV/EBIT Ratio | 11.54 | 12.57 | 20.01 | 49.73 | 18.99 | 27.55 | Upgrade
|
| EV/FCF Ratio | - | 8.24 | 6.76 | 12.47 | 11.83 | 21.15 | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.33 | 0.48 | 0.67 | 0.77 | 1.07 | Upgrade
|
| Debt / EBITDA Ratio | 1.30 | 1.43 | 2.38 | 4.11 | 3.22 | 4.35 | Upgrade
|
| Debt / FCF Ratio | - | 1.78 | 2.13 | 4.45 | 4.18 | 7.05 | Upgrade
|
| Net Debt / Equity Ratio | 0.19 | 0.19 | 0.31 | 0.48 | 0.60 | 0.89 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.73 | 0.81 | 1.53 | 2.98 | 2.53 | 3.65 | Upgrade
|
| Net Debt / FCF Ratio | - | 0.99 | 1.36 | 3.19 | 3.27 | 5.89 | Upgrade
|
| Asset Turnover | - | 0.68 | 0.62 | 0.57 | 0.63 | 0.60 | Upgrade
|
| Inventory Turnover | - | 3.41 | 3.30 | 3.28 | 3.62 | 3.20 | Upgrade
|
| Quick Ratio | - | 0.58 | 0.59 | 0.62 | 0.59 | 0.45 | Upgrade
|
| Current Ratio | - | 0.93 | 0.92 | 0.97 | 0.90 | 0.72 | Upgrade
|
| Return on Equity (ROE) | - | 6.28% | 6.99% | -1.16% | 6.27% | 6.55% | Upgrade
|
| Return on Assets (ROA) | - | 4.37% | 2.45% | 1.09% | 3.13% | 2.66% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.49% | 6.70% | 4.58% | 2.46% | 5.04% | 4.80% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 11.80% | 6.70% | 2.90% | 8.20% | 8.10% | Upgrade
|
| Earnings Yield | 5.27% | 4.70% | 6.20% | -0.84% | 3.78% | 2.91% | Upgrade
|
| FCF Yield | - | 14.39% | 20.06% | 11.34% | 11.87% | 6.66% | Upgrade
|
| Dividend Yield | 1.82% | 2.12% | 2.59% | - | 1.60% | 1.05% | Upgrade
|
| Payout Ratio | - | 63.51% | 24.70% | - | 77.99% | 85.71% | Upgrade
|
| Buyback Yield / Dilution | -1.79% | -1.67% | 0.73% | -0.06% | -2.80% | -16.71% | Upgrade
|
| Total Shareholder Return | 0.01% | 0.45% | 3.32% | -0.06% | -1.19% | -15.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.